Sana Biotechnology Inc [NASDAQ: SANA] stock went on an upward path that rose over 5.54% on Wednesday, amounting to a one-week price increase of more than 18.71%.
Over the last 12 months, SANA stock rose by 215.34%. The one-year Sana Biotechnology Inc stock forecast points to a potential upside of 37.32. The average equity rating for SANA stock is currently 1.29, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.16 billion, with 225.46 million shares outstanding and 125.43 million shares in the current float. Compared to the average trading volume of 4.58M shares, SANA stock reached a trading volume of 6271452 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Sana Biotechnology Inc [SANA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SANA shares is $8.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SANA stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Sana Biotechnology Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 03, 2025. The new note on the price target was released on March 18, 2025, representing the official price target for Sana Biotechnology Inc stock. Previously, the target price had yet another raise to $7, while Jefferies analysts kept a Buy rating on SANA stock.
The Price to Book ratio for the last quarter was 5.54, with the Price to Cash per share for the same quarter was set at 0.48.
SANA Stock Performance Analysis:
Sana Biotechnology Inc [SANA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.71. With this latest performance, SANA shares gained by 97.69% in over the last four-week period, additionally plugging by 76.03% over the last 6 months – not to mention a rise of 215.34% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SANA stock in for the last two-week period is set at 81.92, with the RSI for the last a single of trading hit 0.37, and the three-weeks RSI is set at 0.33 for Sana Biotechnology Inc [SANA]. The present Moving Average for the last 50 days of trading for this stock 2.91, while it was recorded at 4.71 for the last single week of trading, and 2.71 for the last 200 days.
Sana Biotechnology Inc (SANA) Capital Structure & Debt Analysis
According to recent financial data for Sana Biotechnology Inc. ( SANA), the Return on Equity (ROE) stands at -71.44%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -37.04%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Sana Biotechnology Inc’s Return on Invested Capital (ROIC) is -72.61%, showcasing its effectiveness in deploying capital for earnings.
Sana Biotechnology Inc (SANA) Efficiency & Liquidity Metrics
Based on Sana Biotechnology Inc’s (SANA) latest financial statements, the Debt-to-Equity Ratio is 0.44%, indicating its reliance on debt financing relative to shareholder equity.
Sana Biotechnology Inc (SANA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Sana Biotechnology Inc. (SANA) effectively leverages its workforce, generating an average of -$1075618.56 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.40% and a Quick Ratio of 3.40%, indicating strong ability to cover short-term liabilities.
SANA Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SANA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sana Biotechnology Inc go to 14.13%.
Sana Biotechnology Inc [SANA] Institutonal Ownership Details
There are presently around $87.04%, or 95.09% of SANA stock, in the hands of institutional investors. The top three institutional holders of SANA stocks are: FMR LLC with ownership of 27.17 million shares, which is approximately 11.5894%. FLAGSHIP PIONEERING INC., holding 25.0 million shares of the stock with an approximate value of $$136.51 million in SANA stocks shares; and FLAGSHIP PIONEERING INC., currently with $$70.32 million in SANA stock with ownership which is approximately 5.4934%.
